tumor necrosis factor

Recombinant proteinexperimental

Tumor necrosis factor (TNF), formerly known as TNF-α, is a chemical messenger produced by the immune system that induces inflammation. TNF is produced primarily by activated macrophages, and induces inflammation by binding to its receptors on other cells. It is a member of the tumor necrosis factor superfamily, a family of transmembrane proteins that are cytokines, chemical messengers of the immune system. Excessive production of TNF plays a critical role in several inflammatory diseases, and TNF-blocking drugs are often employed to treat these diseases. — Wikipedia

Clinical trial activity

15 trials · 16 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
8
Phase 3
3
Phase 4
0

Earliest trial started Feb 1, 1992 (NCT00001296)

Timeline

1990s

  1. Jan 1, 1992

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 1999

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • tnf alpha
  • tnf-alpha
  • tumor necrosis factor

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07196540Phase 2Sep 26, 2025Sun Yat-Sen University
NCT06433869Phase 2Dec 14, 2023Sun Yat-Sen University
NCT05755685Phase 2Feb 10, 2023Zhejiang University
NCT05433597Phase 2/Phase 3 (Phase 3)Jul 1, 2022Sun Yat-Sen University
NCT01490047Phase 1Jan 1, 2013Johns Hopkins University, J. W. Goethe University, Ludwig Institute for Cancer Research
NCT01347801N/AMar 1, 2011Novo Nordisk, University of Copenhagen
NCT01452958N/AJun 1, 2010Aarhus University, Lundbeck
NCT02456363Phase 2Nov 1, 2009Chung Shan Medical University
NCT00630006N/AJan 1, 2007Kaohsiung Medical University
NCT01953393N/AApr 30, 2006University of Copenhagen
NCT00002262Phase 1Nov 2, 1999University of California, San Francisco
NCT00001004Phase 2Nov 2, 1999National Institute of Allergy and Infectious Diseases (NIAID)
NCT00019968Phase 2Aug 1, 1999National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00003789Phase 3Mar 1, 1999American College of Surgeons, National Cancer Institute (NCI)
NCT00001296Phase 3Feb 1, 1992National Cancer Institute (NCI)
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (16)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government3221992
Sun Yat-Sen UniversityAcademic/Hospital3322022
University of CopenhagenAcademic/Hospital2212006
Aarhus UniversityAcademic/Hospital1112010
American College of SurgeonsAcademic/Hospital1011999
Chung Shan Medical UniversityAcademic/Hospital1112009
Johns Hopkins UniversityAcademic/Hospital1012013
J. W. Goethe UniversityAcademic/Hospital1012013
Kaohsiung Medical UniversityAcademic/Hospital1112007
Ludwig Institute for Cancer ResearchAcademic/Hospital1112013
LundbeckFor profit1012010
National Institute of Allergy and Infectious Diseases (NIAID)Government1111999
National Institutes of Health (NIH)Government1111999
Novo NordiskFor profit1012011
University of California, San FranciscoAcademic/Hospital1111999
Zhejiang UniversityAcademic/Hospital1112023
16 organizations
Page 1 / 1